WJ Gullick

2.0k total citations
26 papers, 1.6k citations indexed

About

WJ Gullick is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, WJ Gullick has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in WJ Gullick's work include HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). WJ Gullick is often cited by papers focused on HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (4 papers). WJ Gullick collaborates with scholars based in United Kingdom, Japan and Italy. WJ Gullick's co-authors include B.A. Gusterson, L. Machin, Fortunato Ciardiello, Diana M. Barnes, Jiřina Bártková, Rosemary R. Millis, Ian O. Ellis, Mitch Dowsett, T Cooke and R A Walker and has published in prestigious journals such as The EMBO Journal, Oncogene and British Journal of Cancer.

In The Last Decade

WJ Gullick

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
WJ Gullick United Kingdom 18 1.1k 751 544 307 269 26 1.6k
B. J. Kerns United States 16 1.2k 1.0× 880 1.2× 383 0.7× 391 1.3× 235 0.9× 25 2.2k
DM Barnes United Kingdom 16 1.3k 1.1× 494 0.7× 439 0.8× 670 2.2× 178 0.7× 18 1.7k
Wendy A. Raymond Australia 20 549 0.5× 697 0.9× 162 0.3× 399 1.3× 235 0.9× 40 1.5k
P Bertheau France 16 800 0.7× 536 0.7× 287 0.5× 456 1.5× 234 0.9× 35 1.5k
Noa Ben-Baruch Israel 16 757 0.7× 524 0.7× 237 0.4× 384 1.3× 232 0.9× 38 1.3k
S M Edgerton United States 13 1.1k 1.0× 748 1.0× 183 0.3× 661 2.2× 199 0.7× 14 1.7k
Holger Dieterich Switzerland 11 793 0.7× 736 1.0× 158 0.3× 579 1.9× 178 0.7× 14 1.6k
Jan Pinkas United States 23 1.5k 1.4× 940 1.3× 783 1.4× 252 0.8× 124 0.5× 71 2.3k
Monica M. Reinholz United States 20 936 0.8× 506 0.7× 372 0.7× 422 1.4× 171 0.6× 38 1.3k
David Huntsman Canada 17 681 0.6× 567 0.8× 128 0.2× 377 1.2× 295 1.1× 28 1.4k

Countries citing papers authored by WJ Gullick

Since Specialization
Citations

This map shows the geographic impact of WJ Gullick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WJ Gullick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WJ Gullick more than expected).

Fields of papers citing papers by WJ Gullick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WJ Gullick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WJ Gullick. The network helps show where WJ Gullick may publish in the future.

Co-authorship network of co-authors of WJ Gullick

This figure shows the co-authorship network connecting the top 25 collaborators of WJ Gullick. A scholar is included among the top collaborators of WJ Gullick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WJ Gullick. WJ Gullick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hill, ME, et al.. (2007). Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer. European Oncology & Haematology. 108–108. 2 indexed citations
2.
Rampaul, R.S., Sarah E. Pinder, WJ Gullick, J.F.R. Robertson, & Ian O. Ellis. (2002). HER-2 in breast cancer—methods of detection, clinical significance and future prospects for treatment. Critical Reviews in Oncology/Hematology. 43(3). 231–244. 19 indexed citations
3.
4.
Dowsett, Mitch, T Cooke, Ian O. Ellis, et al.. (2000). Assessment of HER2 status in breast cancer. European Journal of Cancer. 36(2). 170–176. 92 indexed citations
5.
Ellis, Ian O., Mitch Dowsett, John M.S. Bartlett, et al.. (2000). Recommendations for HER2 testing in the UK. Journal of Clinical Pathology. 53(12). 890–892. 119 indexed citations
6.
Gullick, WJ, et al.. (1999). Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation. Oncogene. 18(20). 3076–3084. 20 indexed citations
7.
Fontanini, Gabriella, Michelino De Laurentiis, S. Vignati, et al.. (1998). Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.. PubMed. 4(1). 241–9. 262 indexed citations
8.
Normanno, Nicola, G Merlo, GR Johnson, et al.. (1994). Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas. British Journal of Cancer. 69(5). 903–910. 105 indexed citations
9.
Gullick, WJ & Alan H. Handyside. (1994). Pre-implantation diagnosis of inherited predisposition to cancer. European Journal of Cancer. 30(13). 2030–2032. 3 indexed citations
10.
Saeki, Toshiaki, David S. Salomon, Nicola Normanno, et al.. (1994). IMMUNOHISTOCHEMICAL DETECTION OF CRIPTO-1, AMPHIREGULIN AND TRANSFORMING GROWTH-FACTOR-ALPHA IN HUMAN GASTRIC CARCINOMAS AND INTESTINAL METAPLASIAS. International Journal of Oncology. 5(2). 215–23. 23 indexed citations
11.
Lofts, F., Helen C. Hurst, Michael J.E. Sternberg, & WJ Gullick. (1993). Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo.. PubMed. 8(10). 2813–20. 55 indexed citations
12.
Prigent, S A, et al.. (1992). Expression of the c-erbB-3 protein in normal human adult and fetal tissues.. PubMed. 7(7). 1273–8. 149 indexed citations
13.
Barnes, David & WJ Gullick. (1992). European society of mastology — biology section meeting on the molecular biology of non-invasive breast cancer. The Breast. 1(2). 109–111. 1 indexed citations
14.
Kumar, Sanjeev, et al.. (1991). Expression of growth factor receptors in human brain tumours. British Journal of Cancer. 63(2). 227–233. 59 indexed citations
15.
Bártková, Jiřina, Diana M. Barnes, Rosemary R. Millis, & WJ Gullick. (1990). Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Human Pathology. 21(11). 1164–1167. 123 indexed citations
16.
Lammie, G A, D M Barnes, R R Millis, & WJ Gullick. (1989). An immunohistochemical study of the presence of c‐erbB‐2 protein in Paget's disease of the nipple. Histopathology. 15(5). 505–514. 71 indexed citations
17.
Quirke, Philip, et al.. (1989). Pattern of expression of c-erbB-2 oncoprotein in human fetuses. British Journal of Cancer. 60(1). 64–69. 55 indexed citations
18.
Wright, Carol, Brian Angus, S Nicholson, et al.. (1988). PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 ONCOPROTEIN EXPRESSION IN BREAST-CANCER - AN IMMUNOHISTOCHEMICAL STUDY. UCL Discovery (University College London). 1 indexed citations
19.
Gusterson, B A, L. Machin, WJ Gullick, et al.. (1988). c-erbB-2 expression in benign and malignant breast disease. British Journal of Cancer. 58(4). 453–457. 167 indexed citations
20.
Gusterson, B.A., L. Machin, WJ Gullick, et al.. (1988). Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancer. International Journal of Cancer. 42(6). 842–845. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. J. Kerns Breakdown of academic impact, for papers by DM Barnes Breakdown of academic impact, for papers by Wendy A. Raymond Breakdown of academic impact, for papers by P Bertheau Breakdown of academic impact, for papers by Noa Ben-Baruch Breakdown of academic impact, for papers by S M Edgerton Breakdown of academic impact, for papers by Holger Dieterich Breakdown of academic impact, for papers by Jan Pinkas Breakdown of academic impact, for papers by Monica M. Reinholz Breakdown of academic impact, for papers by David Huntsman
Rankless by CCL
2026